Litcius/Paper detail

Safety and tolerability of combination therapy with pirfenidone and nintedanib for idiopathic pulmonary fibrosis: A multicenter retrospective observational study in Japan

Shu Hisata, Masashi Bando, Sakae Homma, Kensuke Kataoka, Takashi Ogura, Shinyu Izumi, Susumu Sakamoto, Kizuku Watanabe, Yoshinobu Saito, Yasuo Shimizu, Motoyasu Kato, Yasuhiko Nishioka, Hiromichi Hara, Yuko Waseda, Yoshinori Tanino, Kazuhiro Yatera, Seishu Hashimoto, Hiroshi Mukae, Naohiko Inase

2021Respiratory Investigation23 citationsDOI

Topics & Concepts

PirfenidoneMedicineNintedanibTolerabilityInternal medicineIdiopathic pulmonary fibrosisAdverse effectRetrospective cohort studyGastroenterologyLungInterstitial Lung Diseases and Idiopathic Pulmonary FibrosisLung Cancer Treatments and MutationsSystemic Sclerosis and Related Diseases
Safety and tolerability of combination therapy with pirfenidone and nintedanib for idiopathic pulmonary fibrosis: A multicenter retrospective observational study in Japan | Litcius